---
layout: default
title: Data
nav_order: 3
has_children: true
permalink: docs/data
has_toc: true
---

# Commonly used datasets for POND research
{: .no_toc }

[POND](http://pond.cs.ucl.ac.uk) [emerged](https://ucl-pond.github.io/projects) from [modelling](https://doi.org/10.1007/978-3-642-22092-0_61) the [progression](https://doi.org/10.1016/j.neuroimage.2012.01.062) of Alzheimer's disease and, although we have expanded into other organs, public datasets from studies of Alzheimer's disease are still our bread and butter for a lot of our team.

### ADNI
{: .no_toc }

Data is becoming more readily available, but among the first was from the Alzheimer's Disease Neuroimaging Initiative ([ADNI](https://adni.loni.usc.edu)) study. ADNI is used by thousands of researchers worldwide and by tens of researchers in UCL CMIC alone. To that end, [Neil](https://neiloxtoby.com) is curating a local version on the UCL-CS cluster to centralise and share iamge analyses, reduce duplicate processing, and improve reproducibility. For more information, see the [ADNI@CMIC](/docs/data/adni@cmic) page.

Below is an evolving summary of selected datasets relevant to POND research. Most focus on Alzheimer's disease, most include neuroimaging data, and most are very easy to obtain access.

Please contribute other datasets to this list as they are discovered.

# Table of contents
{: .no_toc .text-delta }

1. TOC
{:toc}

<hr />

# Various data portals

| Portal | Datasets available | 
| ------ | ------------------ |
| [LONI](https://ida.loni.usc.edu)          | ADNI, PPMI, A4, etc. |
| [ADDI](https://www.alzheimersdata.org)    | EPAD, AmyPAD |
| [Vivli](https://vivli.org)                | TOMMORROW |
| [GAAIN](http://www.gaain.org)             | Various |
| [DPUK](https://www.dementiasplatform.uk)  | Various |
| [neuGrid](https://www.neugrid2.eu)        | EMIF-AD |
| [AMP-AD synApse](https://www.synapse.org) | ANMerge, ROSMAP, [TREAT-AD](https://treatad.org/data-tools/) |


<hr />

# Alzheimer's disease and/or ageing

ALZFORUM is an awesome resource for Alzheimer's disease research, including:
- Various [databases](https://www.alzforum.org/databases)
- [Brain banks](https://www.alzforum.org/brain-banks)
- Clinical trials drug programmes: [AlZFORUM therapeutics database](https://www.alzforum.org/therapeutics)

See also this data viewer from Fraunhofer SCAI: [AData(Viewer) Exploring the Alzheimer's Disease Data Landscape](https://adata.scai.fraunhofer.de)

## ADNI

Key information:
- Name: *A*lzheimer's *D*isease *N*euroimaging *I*nitiative
- URL: [adni.loni.usc.edu](http://adni.loni.usc.edu)

Further information:
- Original Paper: [Mueller et al., Alz Dem 2005](https://doi.org/10.1016/j.jalz.2005.06.003)
- Highlights papers
  - 2010: [Weiner et al., Alz Dem 2015](https://doi.org/10.1016/j.jalz.2010.03.007)
  - 2012: [Weiner et al., Alz Dem 2012](https://doi.org/10.1016/j.jalz.2011.09.172)
  - 2004-2014: [Weiner et al., Alz Dem 2015](https://doi.org/10.1016/j.jalz.2015.04.005)
  - 2017: [Weiner et al., Alz Dem 2017](https://doi.org/10.1016/j.jalz.2016.11.007)
  - 2019: [Veitch, et al., Alz Dem 2019](https://doi.org/10.1016/j.jalz.2018.08.005)
  - 2022: [Veitch, et al., Alz Dem 2022](https://doi.org/10.1002/alz.12422)
- ADNI-3 paper: [Weiner et al., Alz Dem 2017](https://doi.org/10.1016/j.jalz.2016.10.006)

## AIBL

Key information:
- Name: *A*ustralian *I*maging, *B*iomarker & *L*ifestyle Flagship Study of Ageing
- URL: [aibl.csiro.au](https://aibl.csiro.au)

## OASIS

Key information:
- Name: *O*pen *A*ccess *S*eries of *I*maging *S*tudies
- URL: [www.oasis-brains.org](https://www.oasis-brains.org)

Further information:
- OASIS-3: [LaMontagne, et al., medRxiv 2019](https://doi.org/10.1101/2019.12.13.19014902)
- OASIS-4: [Koenig, et al., NeuroImage Clinical 2020](https://doi.org/10.1016/j.nicl.2020.102248)

## AmyPAD

Key information:
- Name: *Amy*loid imaging to *P*revent *A*lzheimer's *D*isease
- URL: [amypad.eu](https://amypad.eu)

Further information:
- Original Paper: [Frisoni, et al., Alz Dem 2018](https://doi.org/10.1016/j.jalz.2018.09.003)

## DIAN

Key information:
- Name: *D*ominantly *I*nherited *A*lzheimer's *N*etwork
- URL: [dian.wustl.edu](https://dian.wustl.edu)

Further information:
- Original Paper: [Bateman, et al., N Engl J Med 2012](https://doi.org/10.1056/NEJMoa1202753)
- [Observational Study](https://dian.wustl.edu/our-research/observational-study/)
- Clinical Trials: [DIAN-TU](https://dian.wustl.edu/our-research/clinical-trial/) (primary and secondary prevention)

## EPAD

Key information:
- Name: *E*uropean *P*revention of *A*lzheimer's *D*ementia Consortium
- URL: [ep-ad.org](https://ep-ad.org)

Further information:
- Original Paper: [Ritchie, et al., Lancet Psych 2015](https://doi.org/10.1016/S2215-0366(15)00454-X)

## PREVENT-AD / INTREPAD

Key information:
- PREVENT-AD (observational): *Pr*e-symptomatic *Ev*aluation of *E*xperimental or *N*ovel *T*reatments for *AD*
- INTREPAD (clinical trial): *I*nvestigation of *N*aproxen *Tr*eatment *E*ffects in *P*re-symptomatic *A*lzheimer's *D*isease
- URL: [registeredpreventad.loris.ca](https://registeredpreventad.loris.ca)


Further information:
- [STOP-AD centre](https://prevent-alzheimer.net/?page_id=42&lang=en)
- PREVENT-AD paper: [Tremblay-Mercier, et al., NeuroImage: Clinical 2021](https://doi.org/10.1016/j.nicl.2021.102733)
- INTREPAD paper: [Meyer, et al., Neurology 2019](https://doi.org/10.1212/WNL.0000000000007232)

## A4

Key information:
- Name: *A*nti-*A*myloid Treatment in *A*symptomatic *A*lzheimer’s study
- URL: [a4study.org](https://a4study.org)

Further information:
- ClinicalTrials.gov: [NCT02008357](https://clinicaltrials.gov/ct2/show/NCT02008357)
- First results: [Sperling, et al., JAMA Neurol 2020](10.1001/jamaneurol.2020.0387)
- Recent paper: [Grober, et al., Neurology 2022](https://doi.org/10.1212/wnl.0000000000200046)


## NACC

Key information:
- Name: *N*ational *A*lzheimer's *C*oordinating *C*enter
- URL: [naccdata.org](https://naccdata.org)

Further information?

## CODEC

Key information:
- Name: *Co*gnitive *Dec*line in attenders of memory clinic
- URL: N/A

Further information:
- First (?) paper: [Siddiqui, et al., Dement Geriatr Cogn Disord 2020](https://doi.org/10.1159/000510951)

## ALFA+

Key information:
- Name: *Al*zheimer and *Fa*milies
- URL: [www.barcelonabeta.org/en/alfa-study/study](https://www.barcelonabeta.org/en/alfa-study/study)

Further information:
- Original Paper: [Molinuevo et al., Alzheimers Dement 2016](https://doi.org/10.1016/j.trci.2016.02.003)

## ANMerge

Key information:
- Name: *A*dd*N*euroMed *Merge*
- URL: [doi.org/10.7303/syn22252881](https://doi.org/10.7303/syn22252881)

Further information:
- Primary Paper: [Birkenbihl et al., J Alzheimers Dis 2021](https://doi.org/10.3233/JAD-200948)

## ROS/MAP

Key information:
- Name: *R*eligious *O*rders *S*tudy and *M*emory and *A*ging *P*roject Study
- URL: [adknowledgeportal.synapse.org/...syn3219045](https://adknowledgeportal.synapse.org/Explore/Studies/DetailsPage?Study=syn3219045)

## EMIF-AD

Key information:
- Name: *E*uropean *M*edical *I*nformation *F*ramework
- URL: [www.emif.eu/emif-catalogue/](http://www.emif.eu/emif-catalogue/)
- New URL: [emif-catalogue.eu](https://emif-catalogue.eu/login)
 
Further information:
- Primary Paper: [Bos et al., Alzheimers Res Therapy 2018](https://doi.org/10.1186/s13195-018-0396-5)
<!-- [Vos, et al., Lancet Neurol 2013](https://doi.org/10.1016/s1474-4422(13)70194-7) -->

## Insight46

Key information:
- Name: Neuroscience sub-study of the _MRC National Survey of Health and Development_ (NSHD; also known as the British 1946 Birth Cohort)
- URL: [www.ucl.ac.uk/drc/research/insight-46-study](https://www.ucl.ac.uk/drc/research/insight-46-study)

Further information:
- Protocol Paper: [Lane, et al., BMC Neurology 2017](https://doi.org/10.1186/s12883-017-0846-x)

## ADCS

Key information:
- Name: *A*lzheimer's *D*isease *C*operative *S*tudy
- URL: [www.adcs.org](https://www.adcs.org)

Further information:
- AD trials data available: MCI (donepezil, vitamin E), DHA, IGIV, HC, HU, NS, RES, VN

## CODR / CPAD

[Critical Path Institute](https://c-path.org): [Critical Path For Alzheimer’s Disease](https://c-path.org/programs/cpad/) Database

Key information:
- Name: *C*-Path *O*nline *D*ata *R*epository
- URL: [codr.c-path.org](https://codr.c-path.org)

Further information:
- Non-imaging patient-level data from 12,811 patients across 36 clinical trials of AD and MCI.

## ADCP

Data not yet released.

Key information:
- Name: *A*lzheimer's *D*isease *C*onnectome *P*roject
- URL: [humanconnectome.org/study/alzheimers-disease-connectome-project](https://humanconnectome.org/study/alzheimers-disease-connectome-project)

Further information:
- Original Paper: [Chen et al., J Alzheimers Dis 2016](https://www.ncbi.nlm.nih.gov/pubmed/27567874)



<hr />

# Parkinson's disease

## PPMI

Key information:
- Name: *P*arkinson's *P*rogression *M*arkers *I*nitiative
- URL: [www.ppmi-info.org](https://www.ppmi-info.org)

Further information:
- Primary Paper: [Marek, et al., Progress in Neurobiology 2011](https://doi.org/10.1016/j.pneurobio.2011.09.005)

## PDBP

Key information:
- Name: *P*arkinson's *D*isease *B*iomarker *P*rogram
- URL: [pdbp.ninds.nih.gov](https://pdbp.ninds.nih.gov)

## OPDC Discovery

Key information:
- Name: *O*xford *P*arkinson's *D*isease *C*entre Discovery Cohort
- URLs: [www.opdc.ox.ac.uk](https://www.opdc.ox.ac.uk); [DPUK](https://doi.org/10.48532/036000)

Further information:
- MRI Sub-study Protocol paper: [Griffanti, et al., BMJ Open 2021](https://doi.org/10.1136/bmjopen-2019-034110)
- PD Subtypes paper: [Lawton, et al., J Parkinsons Dis 2015](http://doi.org/10.3233/JPD-140523)

## VIP: Vision in Parkinson's

Key information:
- Name: *V*ision *I*n *P*arkinson's
- URL: [vision-in-parkinsons.co.uk](https://vision-in-parkinsons.co.uk)


<hr />

# Frontotemporal dementia

## GENFI

Key information:
- Name: *Gen*etic *F*TD *I*nitiative
- URL: [www.genfi.org](https://www.genfi.org)

Further information:
- Original Paper: [Rohrer, et al., Lancet Neurol 2015](https://doi.org/10.1016/S1474-4422(14)70324-2)

<hr />

## Huntington's disease

## TRACK-HD / TRACK-ON HD

Key information:
- Name: 
- URL: [DPUK](https://doi.org/10.48532/045000) <!-- (https://portal.dementiasplatform.uk/CohortDirectory/Item?fingerPrintID=TRACK%20HD) -->

Further information:
- Primary Paper: [Tabrizi, et al., JNNP 2012](https://doi.org/10.1136/jnnp-2012-303538.2)

## PREDICT-HD

Key information:
- Name: 
- URL: [via here](https://ega-archive.org/studies/phs000222)


<hr />

# Dementia with Lewy Bodies

## E-DLB

Must be requested directly.

Key information:
- Name: *E*uropean *DLB* consortium
- URL: [www.e-dlb.com/data-sharing](https://www.e-dlb.com/data-sharing/)

<hr />

# Healthy / Ageing

## HCP

Key information:
- Name: *H*uman *C*onnectome *P*roject
- URL: [www.humanconnectomeproject.org/data/](http://www.humanconnectomeproject.org/data/)

<!-- Further information:
- Original Paper: [X et al., X YYYY](https://doi.org/) -->

## HABS

Key information:
- Name: *H*arvard *A*ging *B*rain *S*tudy
- URL: [habs.mgh.harvard.edu](https://habs.mgh.harvard.edu)

<!-- Further information:
- Original Paper: [X et al., X YYYY](https://doi.org/) -->

## UKB

Key information:
- Name: *U*nited *K*ingdom *B*iobank
- URL: [www.ukbiobank.ac.uk](https://www.ukbiobank.ac.uk)

## RSA

Key information:
- Name: *R*otterdam *S*tudy of *A*geing
- URL: [www.erasmus-epidemiology.nl/research/ergo.htm](http://www.erasmus-epidemiology.nl/research/ergo.htm)

Further information:
- 2014 Paper: [Hofman, et al., Eur J Epidemiol 2013](https://doi.org/10.1007/s10654-013-9866-z)

<hr />

# Others

WIP: lungs, etc.
